Rapid Micro Biosystems, Inc.
General ticker "RPID" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $145.7M (TTM average)
Rapid Micro Biosystems, Inc. does not follow the US Stock Market performance with the rate: -20.1%.
Estimated limits based on current volatility of 3.4%: low 1.45$, high 1.55$
Factors to consider:
- Total employees count: 171 (+4.9%) as of 2025
- US accounted for 37.9% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Strategic risks and growth management, Marketing limitations, Intellectual property risks, Geopolitical risks, Economic downturns and volatility
- Current price 22.6% below estimated low
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.80$, 4.23$]
- 2026-12-31 to 2027-12-31 estimated range: [1.54$, 3.72$]
Financial Metrics affecting the RPID estimates:
- Positive: with PPE of -2.8 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -23.34 <= 0.28
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Positive: Investing cash flow per share per price, % of 10.77 > -0.64
- Negative: Industry inventory ratio change (median), % of 0.70 > 0.27
- Positive: 42.26 < Shareholder equity ratio, % of 44.36 <= 63.63
Short-term RPID quotes
Long-term RPID plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $22.52MM | $28.05MM | $33.59MM |
| Operating Expenses | $79.08MM | $77.97MM | $80.98MM |
| Operating Income | $-56.56MM | $-49.92MM | $-47.39MM |
| Non-Operating Income | $4.13MM | $3.05MM | $0.31MM |
| Interest Expense | $0.00MM | $0.04MM | $1.09MM |
| R&D Expense | $12.82MM | $14.60MM | $13.60MM |
| Income(Loss) | $-52.44MM | $-46.87MM | $-47.08MM |
| Taxes | $0.03MM | $0.02MM | $0.04MM |
| Net Income(Loss)* | $-52.47MM | $-46.89MM | $-47.12MM |
| Stockholders Equity | $117.99MM | $75.35MM | $33.21MM |
| Inventory | $19.96MM | $20.20MM | $17.59MM |
| Assets | $143.45MM | $98.17MM | $74.85MM |
| Operating Cash Flow | $-45.08MM | $-44.15MM | $-31.06MM |
| Capital expenditure | $1.84MM | $1.36MM | $0.85MM |
| Investing Cash Flow | $42.15MM | $36.66MM | $14.33MM |
| Financing Cash Flow | $0.15MM | $0.20MM | $19.77MM |
| Earnings Per Share** | $-1.22 | $-1.08 | $-1.05 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.